Andrew Spicer is the CEO of Algenuity and a Director of Spicer Consulting Limited. Andrew received a Ph.D. in molecular and cell biology in 1993 from University College London through his doctoral research at the Imperial Cancer Research Fund (now Cancer Research UK) Laboratories in Lincoln’s Inn Fields, London.
He went on to complete a postdoctoral research fellowship at the Mayo Clinic Scottsdale. He has published over 35 research articles in peer-reviewed journals, and is an acknowledged expert in gene characterisation, expression, manipulation and function in eukaryotes. His articles have collectively been cited over 3000 times since publication. Andrew joined Spicer Consulting to spearhead the development of the Algal Biotech Division in 2009. He is now an acting scientific advisor on several national and international high-profile algal biotechnology research projects, and a member of the management board of the UK's Phyconet Network in Industrial Biotechnology.
Michael Yates serves as Head of Business Development for Algenuity. Prior to working for Algenuity, Michael worked for a nonprofit organisation in Boston, USA, where he pioneered a social entrepreneurship project serving townships in South Africa. Michael is a graduate of MIT.
Jane Purton supports the company as the Operations Manager. She has worked in a number of roles for multinational companies, local government, large business enterprises and start-up ventures. Jane has a varied background in business administration, finance and product quality.